相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emerging Concepts in the Pathology and Molecular Biology of Advanced Non-Small Cell Lung Cancer
Peter Kulesza et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
A National Agenda for the Future of Pathology in Personalized Medicine Report of the Proceedings of a Meeting at the Banbury Conference Center on Genome-Era Pathology, Precision Diagnostics, and Preemptive Care: A Stakeholder Summit
Peter J. Tonellato et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Genomic Pathology Challenges for Implementation
Philip T. Cagle et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2011)
KRAS and BRAF Mutation Analysis in Metastatic Colorectal Cancer: A Cost-effectiveness Analysis from a Swiss Perspective
Patricia R. Blank et al.
CLINICAL CANCER RESEARCH (2011)
The Association for Molecular Pathology's Approach to Supporting a Global Agenda to Embrace Personalized Genomic Medicine
Jane Gibson et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Molecular Profiling of Cancer-The Future of Personalized Cancer Medicine: A Primer on Cancer Biology and the Tools Necessary to Bring Molecular Testing to the Clinic
Thomas Stricker et al.
SEMINARS IN ONCOLOGY (2011)
Clinical Implementation of Comprehensive Strategies to Characterize Cancer Genomes: Opportunities and Challenges
Laura E. MacConaill et al.
CANCER DISCOVERY (2011)
The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside
Joanne S Luciano et al.
Journal of Biomedical Semantics (2011)
Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategies
Patricia R. Blank et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Mining Tissue Microarray Data to Uncover Combinations of Biomarker Expression Patterns that Improve Intermediate Staging and Grading of Clear Cell Renal Cell Cancer
Corinne Dahinden et al.
CLINICAL CANCER RESEARCH (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop
Robert Pirker et al.
Journal of Thoracic Oncology (2010)
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Nallasivam Palanisamy et al.
NATURE MEDICINE (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer A Critical and Systematic Review
Patricia R. Blank et al.
PHARMACOECONOMICS (2010)
Do-it-yourself genetic testing
Steven L. Salzberg et al.
GENOME BIOLOGY (2010)
KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection
Antonio Jimeno et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program
J. H. J. M. van Krieken et al.
VIRCHOWS ARCHIV (2008)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Gastrointestinal stromal tumour
Brian P. Rubin et al.
LANCET (2007)
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E. Geyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Personalized medicine and development of targeted therapies: the upcoming challenge for diagnostic molecular pathology. A review
Manfred Dietel et al.
VIRCHOWS ARCHIV (2006)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Functional genomics, gene arrays, and the future of pathology
E Gabrielson et al.
MODERN PATHOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
分享论文
